Celltrion has partnered with Japan’s largest bio cluster, the Kobe Biomedical Innovation Cluster (KBIC), to support the global expansion of promising biotech startups. The collaboration was announced at an offline briefing held on the 8th at the Tokyo LINK‑J (Life Science Innovation Network Japan) headquarters.
The initiative, named the “2026 KBIC‑Celltrion Global Scale‑up Program,” marks the first time a Korean company co‑plans and operates a program with a Japanese bio cluster, representing a historic Korea‑Japan public‑private partnership aimed at accelerating biotech innovation and market entry.
每日新闻2026年9月20日•1 分钟阅读
Celltrion & Kobe Cluster Launch 2026 Global Scale‑up Program
Celltrion announced a partnership with Japan’s Kobe Biomedical Innovation Cluster, launching the 2026 KBIC‑Celltrion Global Scale‑up Program to help promising biotech startups expand globally.
由 PharmaCountry 团队整理 · 来源: KPA News
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分